GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION
02 mai 2024 09h00 HE
|
GlucoTrack, Inc.
Continuous blood glucose monitor’s preclinical data and sensor longevity modeling to be presented at major diabetes conference Rutherford, NJ, May 02, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc....
Nemaura Medical to Exhibit and Provide Live Product Demonstrations of Its Non-invasive Glucose Sensor at the 83rd Scientific Sessions of the American Diabetes Association June 23-26, 2023
15 juin 2023 08h00 HE
|
Nemaura Medical, Inc
LOUGHBOROUGH, June 15, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive...
Simplify Healthcare supports Maker’s Merci in donating $5K to the American Diabetes Association to improve the lives of diabetics
20 sept. 2021 14h43 HE
|
Simplify Healthcare
Aurora, IL, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Simplify Healthcare is proud to support its not-for-profit affiliate, Maker’s Merci in donating $5,000 to the American Diabetes Association (ADA) for...
Zealand Pharma presents clinical and non-clinical evidence for dasiglucagon rescue therapy at the 80th Scientific Sessions of the American Diabetes Association
14 juin 2020 11h00 HE
|
Zealand Pharma
Press release – No. 09 / 2020 Zealand Pharma presents clinical and non-clinical evidence for dasiglucagon rescue therapy at the 80th Scientific Sessions of the American Diabetes Association...
Amarantus Announces Positive Pre-Clinical Data for MANF in Wolfram Syndrome Presented at the 79th Annual Scientific Sessions of the American Diabetes Association
18 juin 2019 08h00 HE
|
Amarantus Bioscience Holdings, Inc.
NEW YORK, NY, June 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the “Company,” or AMBS), a US-based JLABS-alumnus biotechnology holding...
Finalists Announced for 2018 Diabetes Innovation Challenge
24 avr. 2018 08h10 HE
|
T1D Exchange
BOSTON, April 24, 2018 (GLOBE NEWSWIRE) -- T1D Exchange, a nonprofit patient-centered research organization dedicated to accelerating novel treatments to improve the lives of people with type 1...
Innovators From 17 Countries Vie for $250,000 in Cash and In-Kind Support to Advance Diabetes Care in the 2018 Diabetes Innovation Challenge
20 mars 2018 08h15 HE
|
T1D Exchange
BOSTON, March 20, 2018 (GLOBE NEWSWIRE) -- T1D Exchange, a nonprofit research and collaboration organization dedicated to accelerating novel treatments to improve the care of people living with type...
More than One Third of Louisiana Adults Have Prediabetes, Increased Risk for Serious Health Problems
29 janv. 2018 12h30 HE
|
Louisiana Public Health Institute
New Orleans, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Across Louisiana, more than 35 percent of adults have prediabetes and are at an increased risk for serious health complications including kidney...
Solera Health and the American Diabetes Association® Collaborate to Help Prevent and Delay Type 2 Diabetes for Millions of Americans
18 oct. 2017 10h00 HE
|
Solera Health
PHOENIX, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Solera Health (Solera), a preventive care benefits manager, today announced that they have joined forces with the American Diabetes Association...
Xeris Pharmaceuticals Announces New Results From Ready-To-Use Liquid Glucagon Clinical Development Program
16 juin 2017 07h51 HE
|
Xeris Pharmaceuticals, Inc.
CHICAGO, IL and AUSTIN, TX, June 16, 2017 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”) announced today that results from three clinical studies of the company’s investigational...